LEVOTHYROXINE SODIUM

Alembic's levothyroxine sodium abbreviated new drug application (ANDA 216370, Supplement 006) received approval.

Alembic received FDA approval for levothyroxine sodium (NDA 216370, supplement 005).

Alembic's levothyroxine sodium product (NDA 216370, Supplement 003) was added to the FDA product database.

Alembic's levothyroxine sodium product (NDA 216370, strength 001) was added to the FDA product database.

Alembic received FDA approval for levothyroxine sodium (ANDA 216370, Supplement 004).

Alembic's levothyroxine sodium product (NDA 216370, supplement 012) was added to FDA records.

Alembic's levothyroxine sodium product (NDA 216370, supplement 008) was added to the FDA database.

Alembic's levothyroxine sodium application (NDA 216370, supplement 009) was added to the FDA product database.

Alembic's levothyroxine sodium oral product (NDA 216370, Supplement 002) was added to the FDA's approved drug database.

Alembic's levothyroxine sodium product (NDA 216370, strength 010) was added to the FDA product database.

Alembic's levothyroxine sodium product (NDA 216370, supplement 011) was added to the FDA product database.

Alembic received FDA approval for levothyroxine sodium (ANDA 216370, approval 007).